Boston Scientific Launches $150 Million China Expansion, Shifting Resources From The West
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - U.S. medical device manufacturer Boston Scientific will invest $150 million over the next five years to expand its commercial presence in China and establish R&D and manufacturing operations as the company undergoes a global restructuring initiative